JP Morgan Chase
IRWD icon

JP Morgan Chase’s Ironwood Pharmaceuticals IRWD Stock Holding History

JP Morgan Chase’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-151,041
Closed -$2.33M – 5797
2018
Q3 		$2.33M Buy
151,041
+59,700
+65% +$944K ﹤0.01% 3348
2018
Q2 		$1.46M Buy
+91,341
New +$1.35M ﹤0.01% 3616
2016
Q3 		– Sell
-74,625
Closed -$817K – 4669
2016
Q2 		$817K Buy
+74,625
New +$729K ﹤0.01% 3252

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase's IRWD Position: Q1 2026 in Review

JP Morgan Chase reduced its Ironwood Pharmaceuticals (IRWD) stake by 45% in Q1 2026, selling an estimated $395K and leaving 118,191 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #5174.

JP Morgan Chase first reported a position in IRWD in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.6M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • JP Morgan Chase held 118,191 shares of Ironwood Pharmaceuticals worth $382K as of Q1 2026.
  • JP Morgan Chase sold 96,416 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $395K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5174 holding.
  • JP Morgan Chase first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • JP Morgan Chase's Ironwood Pharmaceuticals position peaked at $24.6M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.